Gregory T Schiffman's Net Worth

$16.4 Million

Estimate Recalculated Apr 17, 2024 06:10PM EST

Who is Gregory T Schiffman?

Gregory T Schiffman has an estimated net worth of $16.4 Million. This is based on reported shares across multiple companies, which include XENOGEN CORP, Absci Corp, Lion Biotechnologies, Inc., STEMCELLS INC, AYRO, Inc., NANOMIX Corp, DENDREON CORP, AFFYMETRIX INC, VNUS MEDICAL TECHNOLOGIES INC, and IMPAC MEDICAL SYSTEMS INC.

SEC CIK

Gregory T Schiffman's CIK is 0001239011

Past Insider Trading and Trends

2005 was Gregory T Schiffman's most active year for acquiring shares with 13 total transactions. Gregory T Schiffman's most active month to acquire stocks was the month of December. 2005 was Gregory T Schiffman's most active year for disposing of shares, totalling 23 transactions. Gregory T Schiffman's most active month to dispose stocks was the month of December. 2010 saw Gregory T Schiffman paying a total of $1,699,473.20 for 109,608 shares, this is the most they've acquired in one year. In 2010 Gregory T Schiffman cashed out on 165,300 shares for a total of $7,033,953.53, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

XENOGEN CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-13.08K
—
—
0
Aug 9
Form 4
+61.87%
5K
—
$5.00
13.08K
Jun 7
Form 4
∞
8.08K
—
—
8.08K
Jan 13
Form 3
—
0
—
—
0
No matching records found

Absci Corp (ABSI) Snapshot price: $4.34

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
+9.01%
50K
$1.10
$55,000.00
605.16K
Oct 20
Form 4
—
0
—
—
0
Feb 21
Form 3
—
0
—
—
0
No matching records found

Lion Biotechnologies, Inc. (IOVA) Snapshot price: $8.2

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 14
Form 3
—
0
—
—
0
No matching records found

STEMCELLS INC (MBOT) Snapshot price: $1.24

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+11.58%
166K
$0.30
$49,800.00
1.6M
Mar 14
Form 4
+81.84%
720K
—
—
1.6M
Mar 15
Form 4
+23.26%
166K
$0.30
$49,800.00
879.72K
Mar 14
Form 4
-3.51%
-25.98K
$0.38
-$9,870.88
713.72K
Jan 8
Form 4
-4.92%
-38.31K
$0.42
-$16,088.94
739.69K
Jan 1
Form 4
+122.29%
428K
—
—
778K
Jan 8
Form 4
∞
350K
—
—
350K
Jan 1
Form 3
—
0
—
—
0
No matching records found

AYRO, Inc. (AYRO) Snapshot price: $1.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.20%
-7.27K
$0.82
-$5,930.49
220.25K
Aug 1
Form 4
-2.91%
-6.81K
$0.49
-$3,319.87
227.53K
May 3
Form 4
+86.33%
108.57K
$0.71
-$2,911.65
234.34K
Scheduled
Jan 30 - Feb 1
Form 4
-8.11%
-11.10K
$0.73
-$8,136.99
125.77K
Scheduled
May 11 - Nov 1
Form 4
+91.80%
65.5K
—
—
136.86K
Feb 1
Form 4
-3.43%
-2.54K
$1.64
-$4,148.27
71.36K
Scheduled
Jan 5
Form 4
-3.32%
-2.54K
$3.20
-$8,115.30
73.89K
Scheduled
Oct 5
Form 4
-6.22%
-5.07K
$4.30
-$21,798.97
76.43K
Scheduled
Aug 4
Form 4
-22.73%
-23.98K
$5.12
-$122,794.39
81.5K
Jun 3
Form 4
+32.71%
26K
—
—
105.48K
Feb 24
Form 4/A
+1,854.70%
75.41K
—
—
79.48K
Sep 29
Form 4
+1,854.70%
75.41K
—
—
79.48K
Sep 29
Form 4
+106.05%
4.07K
—
—
7.9K
May 28
Form 4
∞
50.81K
$0.78
-$9,732.06
50.81K
Aug 27
Form 4
—
0
—
—
0
May 14
Form 3
—
0
—
—
0
No matching records found